E A Thompson|A W Edwards - JoVE Visualize

Showing results (201-210 of 288) with videos related to

Pageof 29

Sort By:

British Journal of Cancer|May 1, 1989

Effect of verapamil on cell cycle transit and c-myc gene expression in normal and malignant murine cellsK R Huber, W F Schmidt, E A Thompson, et al.

The American Naturalist|September 25, 2008

Genetic maternity and paternity in a local population of armadillos assessed by microsatellite DNA markers and field dataP A Prodöhl, W J Loughry, C M McDonough, et al.

American Journal of Medical Genetics. Part A|February 28, 2008

Molecular cytogenetic characterization of a unique and complex de novo 8p rearrangementSusanna L Cooke, Jill K Northup, Neena L Champaige, et al.

Genome Research|January 22, 2011

Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubblesKaren D Howarth, Jessica C M Pole, Juliet C Beavis, et al.

Oncogene|April 23, 2008

Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancerL A Frederick, J A Matthews, L Jamieson, et al.

European Journal of Cancer Care|October 20, 2007

Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care?M A Evans, A R G Shaw, D J Sharp, et al.

Cellular and Molecular Life Sciences : CMLS|September 28, 2019

Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylationBethany Mason, Susanne Flach, Felipe R Teixeira, et al.

F1000Research|September 6, 2016

Whole-genome sequencing of nine esophageal adenocarcinoma cell linesGianmarco Contino, Matthew D Eldridge, Maria Secrier, et al.

International Journal of Cancer|November 11, 2006

Genomic analysis of the 8p11-12 amplicon in familial breast cancerLorenzo Melchor, Maria J Garcia, Emiliano Honrado, et al.

Science Signaling|June 17, 2011

A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. CookAnnette S Little, Kathryn Balmanno, Matthew J Sale, et al.

Pageof 29

Showing results (201-210 of 288) with videos related to

Sort By:

Pageof 29

British Journal of Cancer|May 1, 1989

Effect of verapamil on cell cycle transit and c-myc gene expression in normal and malignant murine cellsK R Huber, W F Schmidt, E A Thompson, et al.

The American Naturalist|September 25, 2008

Genetic maternity and paternity in a local population of armadillos assessed by microsatellite DNA markers and field dataP A Prodöhl, W J Loughry, C M McDonough, et al.

American Journal of Medical Genetics. Part A|February 28, 2008

Molecular cytogenetic characterization of a unique and complex de novo 8p rearrangementSusanna L Cooke, Jill K Northup, Neena L Champaige, et al.

Genome Research|January 22, 2011

Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubblesKaren D Howarth, Jessica C M Pole, Juliet C Beavis, et al.

Oncogene|April 23, 2008

Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancerL A Frederick, J A Matthews, L Jamieson, et al.

European Journal of Cancer Care|October 20, 2007

Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care?M A Evans, A R G Shaw, D J Sharp, et al.

Cellular and Molecular Life Sciences : CMLS|September 28, 2019

Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylationBethany Mason, Susanne Flach, Felipe R Teixeira, et al.

F1000Research|September 6, 2016

Whole-genome sequencing of nine esophageal adenocarcinoma cell linesGianmarco Contino, Matthew D Eldridge, Maria Secrier, et al.

International Journal of Cancer|November 11, 2006

Genomic analysis of the 8p11-12 amplicon in familial breast cancerLorenzo Melchor, Maria J Garcia, Emiliano Honrado, et al.

Science Signaling|June 17, 2011

A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. CookAnnette S Little, Kathryn Balmanno, Matthew J Sale, et al.

Pageof 29